These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2214766)

  • 21. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of estrogen- and antiestrogen-receptor complexes with polynucleotides.
    Murphy LC; Sutherland RL
    Endocrinology; 1983 Feb; 112(2):707-14. PubMed ID: 6848368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subunit composition of the molybdate-stabilized "8-9 S" nontransformed estradiol receptor purified from calf uterus.
    Redeuilh G; Moncharmont B; Secco C; Baulieu EE
    J Biol Chem; 1987 May; 262(15):6969-75. PubMed ID: 3584104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.
    Tate AC; DeSombre ER; Greene GL; Jensen EV; Jordan VC
    Breast Cancer Res Treat; 1983; 3(3):267-77. PubMed ID: 6671136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific antibodies to the DNA-binding domain of estrogen receptor distinguish this protein from the 3H-estradiol-binding protein in pancreas.
    Grossman A; Traish A
    Life Sci; 1992; 51(11):859-67. PubMed ID: 1381803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the estrogen receptor from N-nitrosomethylurea-induced rat mammary tumors.
    Dietrich W; Görlich M; Helbing D; Heise E
    J Steroid Biochem; 1988 Jan; 29(1):77-85. PubMed ID: 3347053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific binding of estrogen and estrogen-receptor complex by microsomes from estrogen-responsive tissues of the rat.
    Watson GH; Muldoon TG
    Endocrinology; 1985 Oct; 117(4):1341-9. PubMed ID: 4029080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired conversion of rat uterine estradiol receptors during aging.
    Chuknyiska RS; Justiniano C; Roth GS
    Exp Gerontol; 1986; 21(4-5):255-65. PubMed ID: 3817038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antiestrogen-binding protein in human tissues.
    Kon OL
    J Biol Chem; 1983 Mar; 258(5):3173-7. PubMed ID: 6826555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
    Giambiagi N; Pasqualini JR
    J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of membrane estrogen binding proteins from rabbit uterus.
    Monje P; Boland R
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):75-84. PubMed ID: 10195694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of estrogen receptors from MCF-7 human breast cancer cells.
    Chong MT; Lippman M
    Cancer Res; 1980 Sep; 40(9):3172-6. PubMed ID: 7427936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
    Aliau S; Groblewski T; Borgna JL
    Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
    Metzger DA; Curtis S; Korach KS
    Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.